Patents by Inventor Jean-Philippe Hugnot

Jean-Philippe Hugnot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody directed against the endothelin receptor beta sub-type
    Patent number: 11312780
    Abstract: Antibodies directed against the endothelin receptor sub-type B, in particular monoclonal antibodies, a fragment or derivative thereof. The present disclosure also relates to the therapeutic, diagnostic use or as a research tool of such an antibody in the field of cancers and in particular glioblastoma.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: April 26, 2022
    Assignee: COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES
    Inventors: Didier Boquet, Frédéric Ducancel, Amaury Herbet, Narciso Costa, Jean-Philippe Hugnot
  • ANTIBODY AGAINST THE ENDOTHELIN RECEPTOR SUBTYPE A, AND USES THEREOF
    Publication number: 20220089755
    Abstract: The present invention relates to antibodies against the endothelin receptor subtype A, in particular monoclonal antibodies, fragments or derivatives thereof. The present invention also relates to the therapeutic or diagnostic use of this antibody or as a research tool in the field of cancers, in particular glioblastoma.
    Type: Application
    Filed: February 4, 2019
    Publication date: March 24, 2022
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, Universite de Paris, UNIVERSITE DE MONTPELLIER, Institut National de la Sante et de la recherche Medicale
    Inventors: Didier BOQUET, Amaury HERBET, Frederic DUCANCEL, Narciso COSTA, Jean-Yves COURAUD, Jean-Philippe HUGNOT
  • ANTIBODY DIRECTED AGAINST THE ENDOTHELIN RECEPTOR BETA SUB-TYPE
    Publication number: 20190185574
    Abstract: Antibodies directed against the endothelin receptor sub-type B, in particular monoclonal antibodies, a fragment or derivative thereof. The present disclosure also relates to the therapeutic, diagnostic use or as a research tool of such an antibody in the field of cancers and in particular glioblastoma.
    Type: Application
    Filed: June 22, 2017
    Publication date: June 20, 2019
    Inventors: Didier Boquet, Frédéric Ducancel, Amaury Herbet, Narciso Costa, Jean-Philippe Hugnot
  • SUGAR-ANALOG PHOSPHORUS-CONTAINING HETEROCYCLES HAVING AN ANTI-METASTATIC ACTIVITY
    Publication number: 20150376216
    Abstract: The use of compounds of formula (1) as defined in the description, for reducing or preventing the onset of metastases in a patient suffering from cancer. Pharmaceutical compositions for using in human or veterinary medicine, including at least one compound of formula (1) are also described.
    Type: Application
    Filed: February 25, 2014
    Publication date: December 31, 2015
    Inventors: Norbert BAKALARA, Marcel DELAFORGE, Marc LECOUVEY, Jean-Philippe HUGNOT, Philippe LEGRAND, Jean-Luc PIRAT, David VIRIEUX, Jean-Noel VOLLE
  • PROGNOSIS FOR GLIOMA
    Publication number: 20150038357
    Abstract: Disclosed is a method of determining the survival prognosis of a patient afflicted by a glioma. The method includes assessing the level of expression of one or more specific gene in cells of the glioma.
    Type: Application
    Filed: October 1, 2012
    Publication date: February 5, 2015
    Inventors: Dominique Joubert, Luc Bauchet, Jean-Philippe Hugnot, Ivan Bieche, Rosette Lidereau, Thierry Reme, Hugues Duffau, Valerie Rigau
  • NKX2.2 INHIBITORS AS DRUGS
    Publication number: 20140005249
    Abstract: The present invention relates to NKX2.2 inhibitors such as shRNAs for treating pathologies.
    Type: Application
    Filed: July 21, 2011
    Publication date: January 2, 2014
    Applicants: UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER, INSTITUT CURIE
    Inventors: Jean-Philippe Hugnot, Pierre-Olivier Guichet, Marisa Teigell, Ivan Bieche, Rosette Lidereau, Dominique Joubert, Luc Bauchet, Valerie Rigau
  • BHLH PROTEINS AND THEIR USE AS DRUGS
    Publication number: 20130210739
    Abstract: The present invention relates to at least one protein belonging to the bHLH family and/or at least a nucleic acid molecule coding for the bHLH proteins as drug.
    Type: Application
    Filed: July 21, 2011
    Publication date: August 15, 2013
    Applicants: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES
    Inventors: Jean-Philippe Hugnot, Pierre-Olivier Guichet, Che Serguera, Jacques Mallet
  • Method for production of neurons from cells of a cell line
    Publication number: 20070155012
    Abstract: The invention relates to a method for production of neurons from cells of a cell line which may be differentiated to produce neurons in particular, whereby said cells are cultivated in spheres, preferably by exposing the same to growth factors, such as, for example, EGF (epidermal growth factor) and/or bFGF (basic fibroblast growth factor) or LIF (Leukemia Inhibitory Factor), in a given growth medium, the differentiation in said spheres is induced on forcing the same to adhere to a substrate, after removal of the growth factors EGF and/or bFGF or LIF, and cultivating the same in the growth medium for an appropriate duration. Said method is characterised in that cells of the human embryonic teratocarcinoma NT2 are used.
    Type: Application
    Filed: September 1, 2004
    Publication date: July 5, 2007
    Inventors: Alain Privat, Sophie Marchal, Jean-Philippe Hugnot